SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-21-000055
Filing Date
2021-05-06
Accepted
2021-05-06 17:28:08
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20210331x10q.htm   iXBRL 10-Q 2520165
2 EX-31.1 kdmn-20210331xex31_1.htm EX-31.1 20134
3 EX-31.2 kdmn-20210331xex31_2.htm EX-31.2 20477
4 EX-32.1 kdmn-20210331xex32_1.htm EX-32.1 10112
5 EX-32.2 kdmn-20210331xex32_2.htm EX-32.2 9993
  Complete submission text file 0001557142-21-000055.txt   9789672

Data Files

Seq Description Document Type Size
6 EX-101.SCH kdmn-20210331.xsd EX-101.SCH 40828
7 EX-101.CAL kdmn-20210331_cal.xml EX-101.CAL 57026
8 EX-101.DEF kdmn-20210331_def.xml EX-101.DEF 193681
9 EX-101.LAB kdmn-20210331_lab.xml EX-101.LAB 371505
10 EX-101.PRE kdmn-20210331_pre.xml EX-101.PRE 340920
11 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20210331x10q_htm.xml XML 2287137
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 21899108
SIC: 2834 Pharmaceutical Preparations